Immune protection of stem cell-derived islet cell therapy for treating diabetes
M Tahbaz, E Yoshihara - Frontiers in Endocrinology, 2021 - frontiersin.org
Insulin injection is currently the main therapy for type 1 diabetes (T1D) or late stage of
severe type 2 diabetes (T2D). Human pancreatic islet transplantation confers a significant …
severe type 2 diabetes (T2D). Human pancreatic islet transplantation confers a significant …
Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome
C Allegrucci, YZ Wu, A Thurston… - Human molecular …, 2007 - academic.oup.com
Widespread provision of human embryonic stem cells (hESCs) for therapeutic use, drug
screening and disease modelling will require cell lines sustainable over long periods in …
screening and disease modelling will require cell lines sustainable over long periods in …
Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation …
F Nakajima, K Tokunaga, N Nakatsuji - Stem cells, 2007 - academic.oup.com
Human embryonic stem (hES) cell lines are of great potential in cell transplantation therapy.
However, recipients of such allogeneic transplants probably need treatment with …
However, recipients of such allogeneic transplants probably need treatment with …
Stem cell therapy for cardiac disease
HS Bernstein, D Srivastava - Pediatric research, 2012 - nature.com
Congenital heart disease occurs in 1% of liveborn infants, making it the most common birth
defect worldwide. Many of these children develop heart failure. In addition, both genetic and …
defect worldwide. Many of these children develop heart failure. In addition, both genetic and …
Cell therapy for type 1 diabetes: current and future strategies
Y Aghazadeh, MC Nostro - Current diabetes reports, 2017 - Springer
Abstract Purpose of the Review Type 1 diabetes (T1D) is defined by an autoimmune
destruction of insulin producing β-cells located in the endocrine part of the pancreas, the …
destruction of insulin producing β-cells located in the endocrine part of the pancreas, the …
Pluripotent stem cells for retinal tissue engineering: current status and future prospects
R Singh, O Cuzzani, F Binette, H Sternberg… - Stem cell reviews and …, 2018 - Springer
The retina is a very fine and layered neural tissue, which vitally depends on the preservation
of cells, structure, connectivity and vasculature to maintain vision. There is an urgent need to …
of cells, structure, connectivity and vasculature to maintain vision. There is an urgent need to …
[HTML][HTML] Parthenogenetic stem cells for tissue-engineered heart repair
M Didié, P Christalla, M Rubart… - The Journal of …, 2013 - Am Soc Clin Investig
Cardiac muscle restitution, or true regeneration, is an unmet need in the treatment of
myocardial infarction (MI), prompting a decade of study with stem cells of many kinds …
myocardial infarction (MI), prompting a decade of study with stem cells of many kinds …
HLA homozygous stem cell lines derived from human parthenogenetic blastocysts
ES Revazova, NA Turovets, OD Kochetkova… - Cloning and stem …, 2008 - liebertpub.com
Individual HLA homozygous parthenogenetic human stem cell (hpSC-Hhom) lines have the
potential for cell-based therapy in a significant number of individuals, provided the HLA …
potential for cell-based therapy in a significant number of individuals, provided the HLA …
Potential and limitation of HLA‐based banking of human pluripotent stem cells for cell therapy
C de Rham, J Villard - Journal of immunology research, 2014 - Wiley Online Library
Great hopes have been placed on human pluripotent stem (hPS) cells for therapy. Tissues
or organs derived from hPS cells could be the best solution to cure many different human …
or organs derived from hPS cells could be the best solution to cure many different human …
Developing safe therapies from human pluripotent stem cells
MK Carpenter, J Frey-Vasconcells, MS Rao - Nature biotechnology, 2009 - nature.com
Developing safe therapies from human pluripotent stem cells | Nature Biotechnology Skip to
main content Thank you for visiting nature.com. You are using a browser version with limited …
main content Thank you for visiting nature.com. You are using a browser version with limited …